CLINICAL_TRIALS
trial_result
· 2012-11-20
Clinical Trial Update: Cyproheptadine and Chlorpromazine Effects on Spasticity
Summary
A completed University of Alberta trial investigated the effects of cyproheptadine and chlorpromazine on spasticity in individuals with spinal cord injury.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alberta | Conditions: Spinal Cord Injuries, Muscle Spasticity | Status: COMPLETED